Clinical Trials on Chronic Lymphoproliferative Diseases
Total 376991 results
-
Becton, Dickinson and CompanyCompletedChronic Lymphoproliferative Diseases (CLPD)United States, Switzerland, Spain, United Kingdom, Portugal
-
Geron CorporationCompletedChronic Lymphoproliferative DiseasesUnited States
-
Becton, Dickinson and CompanyRecruitingChronic Lymphoproliferative Diseases (CLPD)Switzerland, United States, Portugal, Spain
-
Gruppo Italiano Studio LinfomiCompletedBendamustine and Rituximab As Salvage Therapy In Patients With Chronic Lymphoproliferative DisordersRelapsed or Refractory Chronic Lymphoproliferative DisordersItaly
-
National Institute of Allergy and Infectious Diseases...RecruitingChronic Granulomatous Disease-associated ColitisUnited States
-
National Cancer Institute (NCI)Active, not recruitingHodgkin Disease | Waldenstrom Macroglobulinemia | Chronic Lymphocytic Leukemia | NonHodgkin Lymphoma | Mixed Lymphoproliferative DiseaseUnited States
-
AbbVieSuspendedChronic Lymphocytic Leukemia (CLL)Israel
-
University of Michigan Rogel Cancer CenterActive, not recruitingRelapsed Chronic Lymphocytic LeukemiaUnited States
-
University Hospital, Clermont-FerrandRecruitingChronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia | CLL | Relapsed Chronic Lymphocytic Leukemia | Progressive Chronic Lymphocytic LeukemiaFrance
-
University Hospital, ToulouseRecruitingChronic Lymphoid LeukemiaFrance
-
AbbVieActive, not recruitingChronic Lymphocytic Leukemia (CLL)Austria, Germany, Switzerland
-
AstraZenecaActive, not recruitingUntreated Chronic Lymphocytic LeukemiaThailand, Vietnam, Philippines, China, Taiwan
-
Kerry RogersActive, not recruitingChronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic LeukemiaUnited States
-
Alaunos TherapeuticsCompletedLymphoma | Multiple Myeloma | Acute Leukemia | Chronic Myeloproliferative Disease | Chronic Lymphoproliferative Disease | Poor-risk Myelodysplasia (MDS)United States
-
University of California, San DiegoPharmacyclics LLC.Active, not recruitingChronic Lymphocytic LeukemiaUnited States
-
AbbVieF. Hoffmann-La Roche Ltd; German CLL Study Group (GCLLSG); Dana-Farber Cancer...RecruitingChronic Lymphocytic Leukemia (CLL)United States, Australia, Austria, Bulgaria, Germany, Italy, Spain, Israel, Brazil, Romania
-
AstraZenecaCompletedChronic Lymphocytic LeukemiaMalaysia, Saudi Arabia, India, Mexico, Brazil, Singapore, Egypt, Taiwan, Argentina, Chile, Colombia, Costa Rica, Dominican Republic, Kuwait, Panama, Turkey, United Arab Emirates
-
Dana-Farber Cancer InstitutePharmacyclics LLC.; The Leukemia and Lymphoma Society; Blood Cancer Research...Active, not recruitingLeukemia | Chronic Lymphocytic LeukemiaUnited States
-
Dana-Farber Cancer InstituteGenentech, Inc.Active, not recruitingChronic Lymphocytic LeukemiaUnited States
-
AbbVieActive, not recruitingChronic Lymphocytic LeukemiaGreece
-
Hoffmann-La RocheCompletedLymphocytic Leukemia, Chronic, Chronic Lymphocytic Leukemia, CancerSerbia
-
National Cancer Institute (NCI)Active, not recruitingStage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic LeukemiaUnited States, Canada
-
Northwestern UniversityGlaxoSmithKline; National Comprehensive Cancer NetworkActive, not recruitingStage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic LeukemiaUnited States, Sweden
-
Gruppo Italiano Malattie EMatologiche dell'AdultoActive, not recruitingAdult Patients | Chronic Lymphocyte LeukemiaItaly
-
AbbVieCompletedCancer | Chronic Lymphocytic Leukemia (CLL)Russian Federation
-
GlaxoSmithKlineCompletedLeukaemia, Lymphocytic, ChronicKorea, Republic of, Japan
-
Novartis PharmaceuticalsCompletedChronic Lymphocytic Leukemia (CLL) | Leukaemia, Lymphocytic, ChronicUnited States, Belgium, Italy, Greece, Russian Federation, Spain, Poland, Czech Republic
-
GlaxoSmithKlineCompletedLeukaemia, Lymphocytic, ChronicJapan
-
GlaxoSmithKlineGenmabCompletedLeukaemia, Lymphocytic, ChronicSweden
-
National Cancer Institute (NCI)Not yet recruitingLeukemia, Lymphocytic, Chronic, B-Cell | B-Cell Chronic Lymphocytic Leukemia | B-Lymphocytic Leukemia, ChronicUnited States
-
Jennifer R. Brown, MD, PhDAstraZeneca; TG Therapeutics, Inc.Active, not recruitingChronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Relapsed Chronic Lymphocytic LeukemiaUnited States
-
Oncology Institute of Southern SwitzerlandActive, not recruitingChronic Lymphocytic LeukemiaItaly, Switzerland
-
Northwell HealthCompletedChronic Lymphocytic LeukemiaUnited States
-
Swiss Group for Clinical Cancer ResearchActive, not recruitingLeukemia | Chronic Lymphocytic Leukemia | Relapsed/Refractory Chronic Lymphocytic LeukemiaSwitzerland
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)Recruiting
-
Nicole LamannaActive, not recruitingChronic Lymphocytic LeukemiaUnited States
-
Gruppo Italiano Studio LinfomiCompletedChronic Lymphocytic LeukaemiaItaly
-
AstraZenecaParexelActive, not recruitingChronic Lymphocytic LeukemiaUnited States, France, Italy, Spain, Sweden, Canada, Denmark, Korea, Republic of, Brazil, Russian Federation, Taiwan, Germany, Australia, Netherlands, Finland, Norway, United Kingdom
-
AstraZenecaRecruitingChronic Lymphocytic Leukaemia (CLL)Germany
-
German CLL Study GroupCancer Trials Ireland; Stichting Hemato-Oncologie voor Volwassenen Nederland... and other collaboratorsActive, not recruitingChronic Lymphoid LeukemiaSpain, Ireland, Austria, Denmark, Israel, Norway, Germany, Switzerland, Italy, Belgium, Finland, Sweden, Netherlands
-
Royal Marsden NHS Foundation TrustCompleted
-
University Hospital TuebingenGlaxoSmithKlineRecruitingChronic Lymphoid Leukemia in RelapseGermany
-
University of California, San DiegoCelgene CorporationCompletedChronic Lymphocytic Leukemia | CLLUnited States
-
National Cancer Institute (NCI)TerminatedRefractory Chronic Lymphocytic Leukemia | Stage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic LeukemiaUnited States
-
National Cancer Institute (NCI)CompletedB-cell Chronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic LeukemiaUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); Celgene CorporationTerminatedChronic Lymphocytic Leukemia | B-cell Chronic Lymphocytic Leukemia | Stage 0 Chronic Lymphocytic Leukemia | Stage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic LeukemiaUnited States
-
AbbVieCompletedChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL)United States
-
AbbVieCompletedCancer | Chronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Leukemia (SLL)Japan
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityCompletedRefractory Chronic Lymphocytic Leukemia | Stage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic LeukemiaUnited States
-
Novartis PharmaceuticalsCompletedLeukaemia, Lymphocytic, ChronicIndia, United Kingdom, Netherlands, Canada, Germany, Greece, Italy, Poland, Russian Federation, Spain, Taiwan, Thailand, United States, Brazil, Bulgaria, Mexico, Romania, Ukraine